Keywords: Valeant Pharma. Pedinol Pharmacal, M&A, Podiatry

Valeant Pharma to acquire podiatry firm Pedinol

Article | 13 April 2012

Print This

In a fourth takeover deal so far this year, Canadian drugmaker Valeant Pharmaceuticals International. (TSX: VRX) says that it has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in